Close

Intrexon (XON)/Oxitec Announces FDA Finds No Significant Impact From Self-limiting Mosquito

Go back to Intrexon (XON)/Oxitec Announces FDA Finds No Significant Impact From Self-limiting Mosquito

FDA Publishes Final Finding of No Significant Impact and Environmental Assessment on Oxitec's Self-limiting Mosquito

August 5, 2016 10:39 AM EDT

OXFORD, United Kingdom, Aug. 5, 2016 /PRNewswire/ -- The US Food and Drug Administration's Center for Veterinary Medicine (FDA-CVM) today published a final finding of no significant impact (FONSI) and final environmental assessment (EA) on Oxitec's self-limiting OX513A Aedes aegypti mosquito for an investigational trial in the Florida Keys.  The finding concludes that a field trial of the Company's genetically engineered (GE) OX513A mosquitoes in Key Haven, Florida, will not result in a significant impact on the environment. 

The publication of the final FONSI and EA follows an FDA-led evaluation of potential... More